AI-driven rapid analysis could revolutionize drug discovery, significantly reducing research timelines and enhancing collaborative efforts.
The post OpenAI uses nearly 2,000 AI agents to analyze brain CRISPR data in 32 minutes appeared first on Crypto Briefing.